“Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY”. Frontier in Medical and Health Research, vol. 4, no. 3, Mar. 2026, pp. 4636-45, https://fmhr.net/index.php/fmhr/article/view/3855.